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Introduction: Drugs are us 
 
The popular trope which depicts the origin of life on earth 
as emerging from a ‘chemical soup’ continues to have an 
enduring hold over the imagination. Of course, whether 
this ‘soup’ was a prebiotic puddle on the surface of this 
third rock from the Sun, originally ‘canned’, superheated 
and pressurised in one of its internal faults, or a kind of 
extraterrestrial material reheated in some way after 
having reached the early Earth from elsewhere in 
universe, may not be known for sure. Nevertheless, 
advances in sciences such as paleogenomics and 
paleohistology have shown us that at least a part of the 
story of the origin of life can be traced in each and every 
cell of our living bodies. 
 
Given that this is the case, it perhaps warrants thinking 
of the human creature as a highly evolved, walking, 
talking, sentient form of chemical soup. The puddle made 
good! Chemistry might not be life, but if we define life as 
the capacity for a chemical process to ‘involute’, become 
organismic and reproduce itself, then clearly questions 
concerning ‘life’ and ‘what we are’ can at least be 
concretely answered in terms of the discourses of 
biochemistry, the organism, the species, genomics – and 
with reference to other concepts formulated within the 
natural and life sciences. In the cultural context shaped 
by such knowledges, drugs, and the study of drugs, 
identified as a particular group of bio-chemical reagents 
with various potentials for altering the dynamics, 
structuration and evolution of ‘chemical organisms’, has 
become the conventional and prevalent sense of 
‘pharmacology’. The word ‘pharmacology’ brings to mind 
the science and knowledge of drugs as a very special set of 
molecules which are essentially sym-biotic. In other 
words, such scientific pharmacology approaches ‘drugs’ as 
chemicals viewed from the perspective of their potential 
for interaction with living organisms. Conventionally, this 
is expressed in terms of the two valences of 
pharmacodynamics and pharmacokinetics. 
Pharmacodynamics refers to interactions between 
organismic receptors and a drug, pharmacokinetics refers 
to the four stages of drugs ‘passing through’ the organism: 
absorption, distribution, metabolism and excretion. 
 
To the humanities or social sciences scholar who may be 
interested drugs - say in the relationship between drugs 
and perception, drugs and popular culture, the social 
dimensions of drug use/abuse and addiction; or, perhaps, 
in drugs and ritual or religion; drugs and crime; drugs 
and creativity, drugs and euthanasia (this list of ‘drugs 
AND...’ something is essentially interminable) - this 
picture of the relationship between the human organism 
and its environment at the level of symbiotic chemistry 
could seem irrelevant or obscure. The workings of drugs 
in terms of, or at the level of, chemistry and of ‘life’, 
discussed in terms of the organismic and the biochemical, 
might appear to be an entirely other kind of matter – in 
both senses of the term. Such a matter, and such bio-
material, can be regarded as quite simply, and 
categorically, unconnected to the various kinds of ‘narco-
cultural’ phenomena that the humanities and social 
sciences are diversely concerned with. Indeed, as a logos 
for ‘drugs’ – for the pharmakon – scientific pharmacology 
may, like other natural sciences, appear to be profoundly 
reductionistic, and systematically so: reductive of ‘the 
human’ to cellular biochemistry; reductive of experience 
and perception to chemical mechanisms and neuro-
electro-chemical events; reductive of love, desire, pain, 
anger and empathy to the chemistry of neuro-
transmission balances and imbalances; reductive of 
species of mystical or shamanic experience to molecular 
processes or entities – for instance, to name just one 
candidate, a substance such as dimethyltriptamine 
(DMT), which has been dubbed the ‘spirit molecule’.  
 
But as I noted a moment ago, even (perhaps especially) 
for scientific pharmacology, a chemical substance is not 
technically speaking a drug unless it is in an affective 
relationship with a living organism. It must, in this sense, 
become active or mobilised. Something has to happen. It 
has to be consumed and incorporated as the two 
aforementioned valences of pharmacodynamics and 
pharmacokenetics implies. This is why the notion of the 
‘possession’ of drug in anything other than a contrived 
context of prosecution for possessing a ‘controlled 
substance’ deemed a criminal offence, amounts to a kind 
of logical absurdity. A ‘substance’ (which is in fact an 
ancient word for the metaphysical concept of the presence 
of a ‘thing’), cannot properly be considered a drug, and 
pharmacology, even scientific pharmacology, is not in fact 
a science of substances at all; it is rather a science of 
processes and, in general, of affective differentiations. It is 
ultimately interested in what happens rather than what 
is. 
 
To a regular scientific pharmacologist (when ‘at work’ at 
least), dwelling on this difference may seem like a 
pointless bit of metaphysics. Besides, don’t we all want 
such pharmacologists to discover new drugs and drug 
therapies which are executable on the basis of the 
isolation of ‘substances’ – magic bullets which can then be 
‘taken’ as medicines, or, indeed, as novel varieties of 
intoxicants. Isn’t it just obscurantist to suggest that 
‘drugs’ are not also substances, or that these 
‘pharmaceutical substances’ – even those on the chemists 
shelf - are not ‘drugs’? Well it may seem so, I admit, but 
this is because it is very difficult to escape the effects of 
the various rhetorics of drugs that are in circulation. But 
what I think it is important (as well as fascinating) to do 
is to attempt to keep open the question of ‘drugs’ as a 
conceptual question, and to critically reflect on the way in 
which the definition of drugs (and, therefore, of 
pharmacology) is in many respects closed down by the 
predominance of scientific pharmacology as the primary 
discourse of drugs and the presumed sole legitimate 
source of drugs expertise. Yet if one considers for a 
moment how wider society designates ‘substances’ as or 
not as ‘drugs’; if one thinks for a moment about the ways 
in which various plants, tonics, beverages, foods, smoking 
mixtures and so forth can be defined as illegal substances 
(that is today what the word ‘drugs’ tends to bring to 
mind for most people); and how an entirely different set of 
pharmaco-logics are always at work in the broader 
understanding of ‘drugs’ in society, then it becomes clear 
that the conceptualisation of drugs is a matter of concern 
far beyond pharmacology ‘proper’. 
 
My point here is simply that there are many possible logoi 
of ‘drugs’; that there are many different forms of drugs 
expertise and sources of wisdom as to how we humans 
might get on better with them than we currently do. In 
suggesting that we get along poorly with drugs, I am 
thinking of everything malignant that might be 
considered a consequence of the ‘war on drugs’: the 
suffering, death and destruction that this war has 
unleashed across the globe. I am also thinking of the 
socio-political ‘control’ of drugs that actually, and counter-
intuitively, gives rise to adulterations, poisonings and 
avoidable overdoses – pseudo-controls, in reality, that are 
not in any way sym-pathetic with the sym-biotic nature of 
the relation between drugs and life. We should also not 
fail to note at this point the hoarding and withholding of 
medicines from vast swathes of the of the world’s 
population in the context of the corporate wealth 
strategies of ‘big pharma’, commodity speculation and the 
geo-politics of the official and unofficial trade in drugs and 
the management of intellectual property. If drugs can be 
considered to be a part of us, literally as well as 
figuratively, as I have suggested, then patenting their 
recipes is arguably on a par with the patenting of 
sequences of genomic code.  
 
Ideally, the only kinds of drug controls that society should 
aim at instituting are those which serve to realign drugs 
generally with the interests of ‘life’. But just what this 
means is precisely what we need to think about most. 
“Choose life!” – a catchphrase with an apparent ‘anti-
drugs’ message popularised through the Irvine Welsh 
novel (and then the Danny Boyle film), Trainspotting, 
could just as well be considered to imply ‘choosing drugs’, 
but meaning ‘choosing drugs well’. Such a refrain, in this 
living book, would count as a speculative ‘pharmacological 
thesis’ in so far as it forces us to ponder the relationship 
between ‘life’ and ‘drugs’ – once more from the beginning 
and repeatedly, and whilst freeing ourselves from the 
handicap of preconceived epistemic boundaries. 
 
I want above all here to suggest that we cannot, and 
ought not, to isolate the many possible pharmacologies 
from one another if we are to understand ‘our 
relationships to drugs’ in the deepest sense. (I have 
chosen to represent several of these in the initial selection 
of material for this interactive experiment with drugs 
publishing.) If are to find answers to questions such as 
‘what are drugs for?’, ‘what are their potentials?’, we have 
to be willing to widen our understanding of what 
constitutes pharmacology as such. We have to rethink our 
understanding of ‘drugs research’. We need to reconsider 
what constitutes legitimate experimentation with drugs. 
We have to reflect, I believe, on the fact, or indeed on the 
facticity – the very materiality – of our ‘narco-being’, and 
how human being has always been a form of ‘being-on-
drugs’. Drugs are integral to the mediation between 
interiority and exteriority and central to the actual, 
material production of a biological boundary between the 
human subject and the environment it inhabits.  
 
 
Sigmund Freud discusses this point of involution of the 
psyche as chemistry in his Project of Scientific Psychology 
(1895) – and, intellectually speaking, he almost went 
down the road to psycho-pharmacology as a means of 
arriving at the possibility of better living through 
chemistry. I have shown elsewhere that Freud decides 
against this route on pragmatic grounds: in his day the 
prospect of the speedy discovery of a suitable range of 
drugs for the clinical challenges he faced was remote. But 
most significantly, despite its distant prospect, he 
nevertheless entertained the theoretical possibility of 
psycho-chemotherapy. Building on the basis of late 
19c.scientific discourses of chemistry, electricity and 
neurophysiology, Freud had begun to theorise, the 
electrochemical and biological nature of proper human 
functioning. His early experiments with cocaine played a 
part both directly and indirectly in this pre-
psychoanalytic trajectory of scientific inquiry. They also 
served, in the form of reworked psychic material, to direct 
him towards his eventual arrival at full-blown 
psychoanalysis. 
 
I recall this here because it was one specific manifestation 
of the historical split between the scientific and 
humanistic modes of wissenschafliche inquiry into ‘life’ 
which can be traced in modern western culture. There are 
many, many others. In the context of this project for 
‘living books about life’, I am particularly drawn to this 
moment of ‘Freudian pharmacology’ – from the ‘Cocaine 
Papers’ (1884-87) to the dream of Irma’s Injection in The 
Interpretation of Dreams (1900) – because this is one point 
at which the split between what C. P. Snow, half a 
century or so later, articulated and popularised as the 
‘two cultures’ can be directly linked with the question of 
drugs. 
 
However, the image of a ‘divided culture’ has often 
created a false impression of decisive bifurcation, whereas 
in reality the division has never entirely held. 
Philosophically speaking there’s ultimately no ground for 
it – or rather its apparent efficacy is the consequence of a 
bifurcation of philosophical traditions. The historical 
division between the sciences and the arts and 
humanities has always been fundamentally political and 
institutional – as indeed is both past and current critique 
of the perceived split. The politics of knowledge (of drugs 
for instance) is caught up in its entirety (and across its 
many forms) with the uses and perceived ab-uses which 
people engage in when they take drugs, whether wilfully 
and individually, or on the basis of authoritative, often 
medical, prescription (and misprescription). Drugs 
‘themselves’ play a part in those politics through their 
‘effects’ – but where are the boundaries of what we call 
the ‘effects’ of drugs? Certainly their effects cannot be 
limited to either the reported effects on ‘drug users’ or 
supposedly objective observations of ‘drugs researchers’. 
As well as being physiological and medical, their effects 
can equally be considered to be economic or sociological in 
character: drugs are commodities, they are criminogenic, 
they are counter-cultural, and so forth. Drugs might 
equally be seen to exhibit a determinative force in relation 
to culture in general - influencing style, taste, ambience, 
aesthetic sensibility, and so forth. Just as gravity twists 
the space-time matrix and yet is not itself outside of 
space-time, drugs contort the surfaces of culture but are 
cultural substances from the first. 
There are numerous, perhaps countless instances where a 
chiasmus of science and the humanities, rather than the 
rending of ‘culture’ into ‘two’, is evident in 
interdisciplinary cross-fertilisation – and this is apparent 
within the diverse field of ‘drugs research’ as this is 
presented in this living book. I have set the ball rolling 
here by including contributions that I believe illustrate 
how this is the case. In doing so I want to indicate how we 
can indeed embrace the idea that ‘we are chemistry’ and 
that ‘drugs are us’, as it were, without subscribing to what 
I would call naive empirico-postivistic reductionism. 
Dialectical thinking has to deal with the positive and the 
negative. Alternatively, perhaps what is called for is an 
anti-dialectical transcendental empiricism and a 
rethinking of immanence of the kind we find in the work 
of Gilles Deleuze, or at least to think along conceptual 
lines that enable us to take drugs seriously in terms of 
drug affects. It is not the case that the humanities have 
been superseded by the natural sciences – that is a 
political myth, when it comes to drugs, or indeed any 
other field of inquiry. We do, nonetheless, have to 
embrace a certain ‘empiricism of the substance’; but also 
to critique it on the basis of ‘it’ being just as much subject 
as substance: drugs are only drugs in their being taken, 
that is ‘subjectivised.’ Subjectivation in this sense does 
not rest on the denial of the empirical, it refers us rather 
to the super-empiricism of life: drugs interact with ‘life’, 
with ‘perception’, with ‘experience’; they alleviate pain; 
they reset the controls of our cells; they facilitate 
transitions in our being in fundamental ways, etc.; and all 
of these things are irreducibly ‘empirically real’.  
 
 
In my view we can embrace this state of affairs 
intellectually, precisely because the pharmakon is a 
special kind of concept to start with; or, rather, as Derrida 
would say, it is neither simply a word nor a concept, it is 
rather a power of differentiation. It signifies at once both 
‘poison’ and ‘cure’ and, therefore, all ‘pharmacologies’ are, 
perhaps in very differing senses, sciences of doses. The 
quest of all drugs research is ultimately the pursuit of 
some sort of ‘measure’ for drugs. There’s always a risk of 
‘overdoing it’; there’s always the chance of nothing 
happening – the risk of a volume like this perhaps. 
There’s always a risk associated with drugs as a theme, a 
topic, a therapy. There is a sense in which drugs also 
represent a ‘chance’ of sorts, a throw of the dice and an 
opportunity. 
 
In curating the collection comprising this volume (at the 
point at which it goes live at least), I have attempted to 
get the mix right so as to provoke interdisciplinary 
thinking around the theme of drugs and pharmacology. 
And I have tried to calibrate for possibility of addition, 
change, reorganisation of boundaries and the rethinking 
of disciplinary overlaps and exchanges through further 
addition, reorganisation and juxtaposition. I have aimed 
to include material which will attract those interested in 
drugs and pharmacology as they already understand 
these things to read the work of others arriving at them 
from entirely different directions. I very much look 
forward to seeing and reading the contributions which 
users from all areas of ‘drugs research’ will add to these 
pages. 
 
 
Notes  
 
1 See my Culture On Drugs: Narco-cultural Studies of 
High Modernity (Manchester: Manchester University 
Press, 2006).  
 
2 These are gathered in Robert Byck (ed.) The Cocaine 
Papers (New York: Stonehill Press, 1974). 
 
3 In 1959 C. P. Snow delivered the annual Rede Lecture 
in Cambridge with the title ‘The Two Cultures and the 
Scientific Revolution’. He spoke of the gap that had 
opened up between literary inquiry and the sciences and 
the breakdown of communication between the two groups 
of intellectuals. Suffice to say here (in lieu of a lengthy 
bibliography) the ‘two cultures’ debate has been a British 
‘culture wars’ chestnut ever since. 
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